Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice-Reference-Cited by-同舟云学术

Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice

Published:2015-11 Issue:11 Volume:46 Page:1582-1591
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Uguen Arnaud,Guéguen Paul,Legoupil Delphine,Bouvier Stéphanie,Costa Sebastian,Duigou Sandrine,Lemasson Gilles,Ledé Françoise,Sassolas Bruno,Talagas Matthieu,Férec Claude,Le Maréchal Cédric,De Braekeleer Marc,Marcorelles Pascale

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference27 articles.

1. Overall survival in patients with metastatic melanoma;Song;Curr Med Res Opin,2015

2. Update on immunotherapy in melanoma;Green;Surg Oncol Clin N Am,2015

3. Targeted therapies in melanoma;Moschos;Surg Oncol Clin N Am,2015

4. Molecular pathology of melanocytic tumors;Busam;Semin Diagn Pathol,2013

5. BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma;Colombino;J Clin Oncol,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microneedles-mediated drug delivery system for the diagnosis and treatment of melanoma;Colloids and Surfaces B: Biointerfaces;2022-11

2. Pathology-based Biomarkers Useful for Clinical Decisions in Melanoma;Archives of Medical Research;2020-11

3. Negative reactions ofBRAFmutation‐specific immunohistochemistry tonon‐V600Emutations ofBRAF;Pathology International;2020-01-23

4. A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer;BMC Genomics;2019-10-23

5. Decalcification can cause the failure of BRAF molecular analyses and anti‐BRAFV600E VE1 immunohistochemistry;Pathology International;2019-03-07